T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.97B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.37B |
| 3 |
lululemon athletica
LULU
|
+$1.32B |
| 4 |
Spotify
SPOT
|
+$1.28B |
| 5 |
ServiceNow
NOW
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.41B |
| 2 |
Northrop Grumman
NOC
|
+$2.36B |
| 3 |
Microsoft
MSFT
|
+$2.2B |
| 4 |
McDonald's
MCD
|
+$1.85B |
| 5 |
Intercontinental Exchange
ICE
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Iovance Biotherapeutics
IOVA
$2.95B
| $180M | 0.02% |
6,509,856
+4,773
| +0.1% | +$109K |
|
502
Lockheed Martin
LMT
$138B
| $180M | 0.02% |
462,527
+6,396
| +1% | +$2.45M |
|
503
Capitol Federal Financial
CFFN
$1.09B
| $179M | 0.02% |
13,047,271
-1,458,172
| -10% | -$20.5M |
|
504
BioMarin Pharmaceuticals
BMRN
$13.3B
| $179M | 0.02% |
2,116,054
-128,267
| -6% | -$9.69M |
|
|
MRTX
505
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $179M | 0.02% |
1,385,379
+48,815
| +4% | +$4.71M |
|
|
BNY
506
Bank of New York Mellon
BNY
$110B
| $178M | 0.02% |
3,543,471
-5,247,974
| -60% | -$250M |
|
|
SWAV
507
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $177M | 0.02% |
4,030,210
+418,013
| +12% | +$15.4M |
|
508
Columbia Banking Systems
COLB
$9.18B
| $176M | 0.02% |
4,325,116
+5,093
| +0.1% | +$198K |
|
|
NEWR
509
DELISTED
New Relic, Inc.
NEWR
| $175M | 0.02% |
2,661,645
-5,214,477
| -66% | -$339M |
|
510
Kemper
KMPR
$1.59B
| $174M | 0.02% |
2,245,647
+96,894
| +5% | +$7.23M |
|
511
Datadog
DDOG
$90.6B
| $172M | 0.02% |
4,555,586
+3,202,886
| +237% | +$115M |
|
512
Illumina
ILMN
$29.1B
| $172M | 0.02% |
533,014
-55,309
| -9% | -$16.8M |
|
513
PagerDuty
PD
$932M
| $171M | 0.02% |
7,298,277
+3,171,975
| +77% | +$78M |
|
514
Rexford Industrial Realty
REXR
$8.12B
| $170M | 0.02% |
3,733,266
+76,322
| +2% | +$3.53M |
|
515
Valvoline
VVV
$4.31B
| $170M | 0.02% |
7,945,626
-1,425,585
| -15% | -$31.5M |
|
516
Acadia Realty Trust
AKR
$2.86B
| $170M | 0.02% |
6,550,684
-404,226
| -6% | -$11.1M |
|
|
TCDA
517
DELISTED
Tricida, Inc. Common Stock
TCDA
| $167M | 0.02% |
4,429,218
+298,472
| +7% | +$11.1M |
|
518
Axsome Therapeutics
AXSM
$11.2B
| $166M | 0.02% |
1,606,991
+898,120
| +127% | +$36.3M |
|
|
TGI
519
DELISTED
Triumph Group
TGI
| $166M | 0.02% |
6,555,841
-117,586
| -2% | -$2.92M |
|
520
Under Armour Class C
UA
$2.25B
| $164M | 0.02% |
8,543,696
+8,155,732
| +2,102% | +$144M |
|
521
Ovintiv
OVV
$17.2B
| $164M | 0.02% |
6,979,716
+6,967,256
| +55,917% | +$149M |
|
522
Towne Bank
TOWN
$3.5B
| $163M | 0.02% |
5,875,506
+25,314
| +0.4% | +$710K |
|
523
McCormick & Company Non-Voting
MKC
$14.6B
| $163M | 0.02% |
1,919,740
+52,416
| +3% | +$4.34M |
|
524
Cannae Holdings
CNNE
$675M
| $162M | 0.02% |
+4,361,031
| New | +$143M |
|
525
Workiva
WK
$4.01B
| $162M | 0.02% |
3,842,462
+428,448
| +13% | +$18M |
|
Similar funds
T. Rowe Price Associates's Q4 2019 Portfolio in Review
As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
- T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
- T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
- T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
- T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
- T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
- T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.